About Poietis :
Biotech company specialized in the development and manufacturing of human tissues by bioprinting, its main mission is the development of new therapeutic solutions based on its expertise in bioprinting technologies and in particular high-resolution laser assisted bioprinting. Poietis has developed the multimodal NGB (« Next Generation Bioprinting ») bio-printing platform declined in two versions: one for in vitro tissue engineering research (NGB-R) and a clinical version (NGB-C) for the production of implantable bioprinted tissues. This multi-modal, automated biomanufacturing platform enables researchers to achieve superior tissue through high resolution, and enables the fabrication of complex tissues with repeatability and reproducibility. Poietis bioprinting technology is the result of innovative research carried out over ten years at Inserm and the University of Bordeaux. Poietis won the iLab competition in 2014, the World Innovation Challenge Phase II in 2017 and recently the EY Disruptive Strategy Award. The company currently employs 35 people.
About Assistance Publique - Hôpitaux de Marseille (AP-HM) :
+33 (0)5 35 54 47 28